PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain.\', \'Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Pamplona, Spain.\', \'IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.\', \'Clínica Universidad de Navarra, Pamplona, Spain.\', \'Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/22221751.2021.1978823
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 34538222
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all